Cargando…
Absolute treatment effects for the primary outcome and all-cause mortality in the cardiovascular outcome trials of new antidiabetic drugs: a meta-analysis of digitalized individual patient data
AIMS: Treatment effects from the large cardiovascular outcome trials (CVOTs) of new antidiabetic drugs are almost exclusively communicated as hazard ratios, although reporting guidelines recommend to report treatment effects also on an absolute scale, e.g. as numbers needed to treat (NNT). We aimed...
Autores principales: | Kuss, Oliver, Akbulut, Cihan, Schlesinger, Sabrina, Georgiev, Asen, Kelm, Malte, Roden, Michael, Wolff, Georg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402762/ https://www.ncbi.nlm.nih.gov/pubmed/35879478 http://dx.doi.org/10.1007/s00592-022-01917-9 |
Ejemplares similares
-
Meta‐analysed numbers needed to treat of novel antidiabetic drugs for cardiovascular outcomes
por: Wolff, Georg, et al.
Publicado: (2022) -
Cardiovascular outcomes and safety with antidiabetic drugs
por: Aldossari, Khaled K.
Publicado: (2018) -
Risk phenotypes of diabetes and association with COVID-19 severity and death: a living systematic review and meta-analysis
por: Schlesinger, Sabrina, et al.
Publicado: (2021) -
How amenable is type 2 diabetes treatment for precision diabetology? A meta-regression of glycaemic control data from 174 randomised trials
por: Kuss, Oliver, et al.
Publicado: (2023) -
Antidiabetic treatment with gliptins: focus on cardiovascular effects and outcomes
por: Fisman, Enrique Z., et al.
Publicado: (2015)